Rajdip Goswami

Rajdip Goswami

Auto-generated profile, based on publicly available information

Rajdip Goswami

Department of Pharmaceutical Technology, School of Health and Medical Sciences, Adamas University, Barasat, Kolkata, India

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 July 2025 in Biomedical Materials & Devices
Verified
Journal Article
Closed access
PDF file
MRMeghamouli Rana
Meghamouli Rana
RGRajdip Goswami
Rajdip Goswami
AAApurbaa Acharya
Apurbaa Acharya
BBBiswajit Basu
Biswajit Basu
SGSourav Ghosh
Sourav Ghosh
Bhupendra G PrajapatiBhupendra G Prajapati
Bhupendra G Prajapati

15 June 2024 in IP International Journal of Comprehensive and Advanced Pharmacology
Verified
Journal Article
Open access
PDF file
Bhupendra G PrajapatiBhupendra G Prajapati
Bhupendra G Prajapati
RGRajdip Goswami
Rajdip Goswami
SSSaikat santra
Saikat santra
BPBhaskar Pal
Bhaskar Pal
BBBiswajit Basu
Biswajit Basu
To Development and Evaluation of Aceclofenac Swellable Matrix Tablets Utilizing Okra (Abelmoschus Esculentus) and Hibiscus Leaf (Hibiscus Rosa-Sinensis) Natural Polymer Mucilage as Release Modifier.This study investigates the development of sustained-release Aceclofenac tablets using natural polymers, Okra Gum and Hibiscus Leaf Mucilage, to enhance drug efficacy, reduce dosing frequency, and minimize adverse effects in the treatment of inflammation and pain.: Sustained-release NSAID formulations using natural polymers like Okra Gum and Hibiscus Leaf Mucilage enhance drug efficacy, patient adherence, and safety by reducing dosing frequency and adverse effects.Non-steroidal anti-inflammatory drugs (NSAIDs), like Aceclofenac, are commonly prescribed for managing inflammation and pain associated with various conditions such as arthritis, musculoskeletal disorders, and post-operative recovery. Despite their effectiveness, traditional NSAIDs often exhibit rapid-release kinetics, necessitating frequent dosing intervals to maintain therapeutic efficacy. However, frequent dosing increases the risk of adverse effects such as gastrointestinal complications, renal impairment, and cardiovascular events. To address these challenges, sustained-release formulations have been developed to prolong drug action and reduce dosing frequency. Natural polymers, such as Okra Gum and Hibiscus Leaf Mucilage, have emerged as promising excipients for sustained drug delivery systems. These natural polymers offer several advantages, including biocompatibility, biodegradability, and the ability to modulate drug release kinetics. By incorporating Okra Gum and Hibiscus Leaf Mucilage into pharmaceutical formulations can improve patient adherence and therapeutic effectiveness while minimizing adverse effects.Fourier Transform Infrared analysis conducted as part of this study demonstrated no chemical interaction between Aceclofenac and the natural polymers, confirming their compatibility for formulation purposes. The formulated tablets met pharmacopoeial specifications for physicochemical properties, ensuring quality and consistency in manufacturing. The optimized formulation exhibited prolonged drug release lasting up to 12 hours, with release kinetics inversely proportional to polymer concentration. Stability studies conducted over a specified period indicated no significant changes in tablet attributes, affirming the robustness of the formulation.The findings of this study confirm the suitability of Okra Gum and Hibiscus Leaf Mucilage as effective release modifiers for Aceclofenac, offering potential benefits for sustained drug delivery in inflammation therapy. By providing valuable insights into the development of improved drug delivery systems using natural polymers, this research contributes to enhanced patient care and treatment outcomes in inflammatory conditions. Further exploration and optimization of natural polymer-based formulations hold promise for advancing drug delivery technologies and improving patient outcomes in clinical practice.

8 August 2025 in Biomedical Materials & Devices
Verified
Journal Article
Closed access
PDF file
KDKoustav Dutta
Koustav Dutta
BBBiswajit Basu
Biswajit Basu
RGRajdip Goswami
Rajdip Goswami
SGSourav Ghosh
Sourav Ghosh
MRMeghamouli Rana
Meghamouli Rana
Bhupendra G PrajapatiBhupendra G Prajapati
Bhupendra G Prajapati

15 June 2025
Verified
Book Chapter
Closed access
PDF file
RGRajdip Goswami
Rajdip Goswami
AGArunava Ghosh
Arunava Ghosh
BPBhaskar Pal
Bhaskar Pal
SSSaikat santra
Saikat santra
MAMahenderan Appukutty
Mahenderan Appukutty
ACAyan Chatterjee
Ayan Chatterjee

28 January 2026 in Regenerative Engineering and Translational Medicine
Verified
Journal Article
Closed access
PDF file
NANaureen Afrose
Naureen Afrose
RIDEB CHAKRABORTYRIDEB CHAKRABORTY
RIDEB CHAKRABORTY
BBBiswajit Basu
Biswajit Basu
RGRajdip Goswami
Rajdip Goswami
Sudarshan SinghSudarshan Singh
Sudarshan Singh
Bhupendra G PrajapatiBhupendra G Prajapati
Bhupendra G Prajapati

16 May 2026
Verified
Book Chapter
Closed access
WAWassim Abou-Kheir
Wassim Abou-Kheir
HAHalima Mohammed Albalushi
Halima Mohammed Albalushi
HBHisham F. Bahmad
Hisham F. Bahmad
SBSneha Banerjee
Sneha Banerjee
ABAvijit Bej
Avijit Bej
ESElnaz Sheydaee
Elnaz Sheydaee